Biomarin Pharmaceutical Inc.’s filing revealed that its GVP, Chief Accounting Officer Burkhart Erin unloaded Company’s shares for reported $64260.0 on Aug 13 ’24. In the deal valued at $90.00 per share,714 shares were sold. As a result of this transaction, Burkhart Erin now holds 14,449 shares worth roughly $-1.02 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Burkhart Erin bought 714 shares, generating $64,260 in total proceeds.
Before that, Mueller Brian sold 5,000 shares. Biomarin Pharmaceutical Inc. shares valued at $375,950 were divested by the EVP, Chief Financial Officer at a price of $75.19 per share. As a result of the transaction, Mueller Brian now holds 72,159 shares, worth roughly $5.07 million.
A number of analysts have revised their coverage, including Bernstein’s analysts, who increased its forecast for the stock in mid August from “a Mkt perform” to “an Outperform”. Robert W. Baird also remained covering BMRN and has decreased its forecast on May 17, 2024 with a “Neutral” recommendation from previously “an Outperform” rating. Evercore ISI started covering the stock on May 14, 2024. It rated BMRN as “an Outperform”.
Price Performance Review of BMRN
On Monday, Biomarin Pharmaceutical Inc. [NASDAQ:BMRN] saw its stock fall -0.11% to $70.27. Over the last five days, the stock has gained 1.90%. Biomarin Pharmaceutical Inc. shares have fallen nearly -27.12% since the year began. Nevertheless, the stocks have fallen -18.80% over the past one year. While a 52-week high of $99.56 was reached on 01/08/24, a 52-week low of $67.75 was recorded on 09/24/24. SMA at 50 days reached $80.65, while 200 days put it at $84.72.
Levels Of Support And Resistance For BMRN Stock
The 24-hour chart illustrates a support level at 69.90, which if violated will result in even more drops to 69.52. On the upside, there is a resistance level at 70.71. A further resistance level may holdings at 71.14. The Relative Strength Index (RSI) on the 14-day chart is 36.38, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.77%. Stochastics %K at 69.03% indicates the stock is a holding.
How much short interest is there in Biomarin Pharmaceutical Inc.?
A steep rise in short interest was recorded in Biomarin Pharmaceutical Inc. stocks on 2024-09-30, dropping by -0.57 million shares to a total of 5.28 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 5.85 million shares. There was a decline of -10.74%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 15, 2023 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $100 price target.
